tiprankstipranks
Sight Sciences (SGHT)
NASDAQ:SGHT
US Market
Holding SGHT?
Track your performance easily

Sight Sciences (SGHT) Earnings Dates, Call Summary & Reports

80 Followers

Earnings Data

Report Date
Mar 20, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
-0.21
Last Year’s EPS
-0.22
Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 10, 2021
|
% Change Since: -34.83%
|
Next Earnings Date:Aug 12, 2021
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture, with some positive developments such as Medicare coverage confirmation and improved cash flow, but also significant challenges including revenue shortfalls and the impact of new LCDs on growth. The company's efforts to improve commercial execution and enhance organizational structures are positive steps forward, but the immediate financial challenges and market restrictions weigh heavily.
Company Guidance
During the Sight Sciences' Q3 2024 earnings call, the company reaffirmed its revenue guidance of $81 million to $83 million for the year and adjusted operating expenses to approximately $104 million to $106 million. Total revenue for Q3 was reported at $20.2 million, marking a 1% increase year-over-year, with surgical glaucoma revenue at $18.6 million and dry eye revenue at $1.5 million. Although the company saw a net loss of $11.1 million, this was an improvement from the previous year's $13 million loss. The company ended the quarter with $118.6 million in cash and cash equivalents and discussed achieving cash flow breakeven without raising additional equity capital. Management highlighted challenges due to the new LCDs impacting combination MIGS procedures, estimating that 10% of procedures historically billed with multiple devices would be affected. However, they expressed confidence in their strategic initiatives, aiming for double-digit surgical glaucoma revenue growth in Q4 2024 and into 2025.
Medicare Coverage Confirmation
Medicare administrative contractors confirmed continued Medicare coverage for cataract surgery procedures performed with a single MIGS procedure, which is crucial for the growth of the surgical glaucoma franchise.
TearCare's Strong Demand
Higher dry eye revenue was driven by demand for TearCare/Smart Lids ahead of a price increase, highlighting significant interest in TearCare as a compelling solution for dry eye patients.
Reduction in Net Loss
The net loss for the third quarter was $11.1 million or $0.22 per share, compared to a net loss of $13 million or $0.27 per share for the third quarter of 2023, indicating improved financial discipline.
Organizational Enhancements
Key organizational changes were made to enhance execution and performance consistency across territories, aiming for better commercial execution.
Cash Flow Improvements
Generated $0.4 million of cash in the quarter, a significant improvement compared to $10 million of cash used in the third quarter of 2023.
---

Sight Sciences (SGHT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SGHT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 12, 20212021 (Q2)
-0.02 / -1.83
-0.178-928.09% (-1.65)
Nov 10, 20212021 (Q3)
-0.26 / -0.43
-0.173-148.55% (-0.26)
Mar 24, 20222021 (Q4)
-0.39 / -0.34
-0.195-74.36% (-0.15)
May 10, 20222022 (Q1)
-0.40 / -0.49
-1.2962.02% (+0.80)
Aug 11, 20222022 (Q2)
-0.46 / -0.50
-1.8372.68% (+1.33)
Nov 10, 20222022 (Q3)
-0.46 / -0.46
-0.43-6.98% (-0.03)
Mar 13, 20232022 (Q4)
-0.42 / -0.35
-0.34-2.94% (>-0.01)
May 04, 20232023 (Q1)
-0.39 / -0.35
-0.4928.57% (+0.14)
Aug 03, 20232023 (Q2)
-0.34 / -0.30
-0.540.00% (+0.20)
Nov 07, 20232023 (Q3)
-0.32 / -0.27
-0.4641.30% (+0.19)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

SGHT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 07, 2024$4.68$4.23-9.62%
Aug 01, 2024$7.42$6.31-14.96%
May 02, 2024$5.61$5.96+6.24%
Mar 07, 2024$4.60$4.88+6.09%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Sight Sciences (SGHT) report earnings?
Sight Sciences (SGHT) is schdueled to report earning on Mar 20, 2025, TBA Not Confirmed.
    What is Sight Sciences (SGHT) earnings time?
    Sight Sciences (SGHT) earnings time is at Mar 20, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SGHT EPS forecast?
          SGHT EPS forecast for the fiscal quarter 2024 (Q4) is -0.21.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis